Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502030551

Medchemexpress LLC Refametinib | 923032-37-5 | MFCD18633256 | 99.8% | 572.34 g·mol⁻¹ | C19H20F3IN2O5S | 5 MG
SDP

Catalog No. 502030551
Encompass_Preferred

Refametinib is an orally active, non-ATP-competitive allosteric inhibitor of MEK1 and MEK2 used in research to modulate MAPK/ERK signaling. It exhibits low-nanomolar potency and is supplied as a high-purity solid for in vitro and preclinical studies.

  • Allosteric MEK1/MEK2 inhibitor with low-nanomolar potency.
  • Reported IC50: MEK1 = 19 nM; MEK2 = 47 nM.
  • High purity suitable for research applications.
  • Solid powder form for convenient dosing and preparation.
  • Recommended storage at low temperatures to preserve stability.

Catalog No. 50-203-0551 Supplier Medchemexpress LLC Supplier No. HY146915MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Refametinib is an orally active, non-ATP-competitive allosteric inhibitor of MEK1 and MEK2 used in research to modulate MAPK/ERK signaling. It exhibits low-nanomolar potency and is supplied as a high-purity solid for in vitro and preclinical studies.

  • Allosteric MEK1/MEK2 inhibitor with low-nanomolar potency.
  • Reported IC50: MEK1 = 19 nM; MEK2 = 47 nM.
  • High purity suitable for research applications.
  • Solid powder form for convenient dosing and preparation.
  • Recommended storage at low temperatures to preserve stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.